somavaratan
Recombinant proteinexperimental
Clinical trial activity
8 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
5
Phase 3
4
Phase 4
0
Earliest trial started Mar 1, 2011 (NCT01359488)
Timeline
Indications
Mechanism of action
- SomatotropinSupplementation
GH1 supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3707323 ↗
Also known as
- somavaratan
- somavaratan
- somavaratan
- vrs-317
- vrs-317
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03145831 | Phase 3 | Mar 31, 2017 | Versartis Inc. |
| NCT02719990 | Phase 2 | Jan 1, 2016 | Premier Research Group, Versartis Inc. |
| NCT02526420 | Phase 2 | Jul 1, 2015 | Premier Research Group, Versartis Inc. |
| NCT02413138 | Phase 2/Phase 3 (Phase 3) | Mar 1, 2015 | Keio University, Versartis Inc. |
| NCT02339090 | Phase 3 | Jan 1, 2015 | Sponsor GmbH, Versartis Inc. |
| NCT02068521 | Phase 2/Phase 3 (Phase 3) | Mar 1, 2014 | Versartis Inc. |
| NCT01718041 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2012 | Versartis Inc. |
| NCT01359488 | Phase 1 | Mar 1, 2011 | Versartis Inc. |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Versartis Inc. | For profit | 8 | 8 | 3 | 2011 |
| Premier Research Group | For profit | 2 | 0 | 1 | 2015 |
| Keio University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Sponsor GmbH | Academic/Hospital | 1 | 0 | 1 | 2015 |
4 organizations
Page 1 / 1